Caribou Biosciences Inc (CRBU)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Sales | 2,559 | 3,977 | 1,476 | 1,586 | 0 |
| Gross Profit | 2,559 | 3,977 | 1,476 | 1,586 | N/A |
| Operating Expenses | 21,783 | 22,593 | 17,440 | 14,761 | 0 |
| Operating Income | -19,224 | -18,616 | -15,964 | -13,175 | N/A |
| Other Income | 1,066 | -2,358 | 1,653 | 16 | 0 |
| Pre-tax Income | -18,158 | -20,974 | -14,311 | -13,159 | 0 |
| Net Income Continuous | -18,479 | -20,974 | -14,311 | -13,159 | N/A |
| Net Income | $-18,479 | $-20,974 | $-14,311 | $-13,159 | $N/A |
| EPS Basic Total Ops | 1.13 | -0.46 | -1.39 | -1.39 | N/A |
| EPS Basic Continuous Ops | 1.12 | -0.46 | -1.39 | -1.39 | N/A |
| EPS Diluted Total Ops | 1.13 | -0.46 | -1.39 | -1.39 | N/A |
| EPS Diluted Continuous Ops | 1.12 | -0.46 | -1.39 | -1.39 | N/A |
| EBITDA(a) | $-18,899 | $-18,356 | $-15,734 | $-12,954 | $N/A |